Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Last updated refers to the date when our listing for each treatment was last updated.
ID is our internal ID - starting with VT.
Min Karnofsky is a general guide to how well you have to function to use this treatment
For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.

Back to New Treatments List



		Treatment Name:		NABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas

		Keywords:		SAHA, temozolomide

		Phase:		Phase 1

		Treatment ID#s:		VT1676 NABTC 04-03

		Age Group:		Adults Only

		Min Karnofsky Score:		70: Cares for self, unable to perform normal activity or to do active work

		Conditions:		Newly Diagnosed: N Recurrent: Y Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed Recurrent malignant glioma must be treated at NABTC institution may not have progressed on temozolomide

		Last Updated:		10/03/2007

		Tumor Types:		Anaplastic Astrocytoma Glioblastoma Multiforme Gliosarcoma Mixed Glioma Oligodendroglioma High Grade


		Comments:

		Treatment Type:		Chemotherapy.

		Contact:		U. Of California At San Francisco Michael Prados, MD Professor Contact: Dr. Michael Prados 400 Parnassus Avenue, Rm A808 San Francisco, CA 94143- Phone:(415)353-2966 Fax: (415)353-2167 Click here to send an email Website: neurosurgery.medschool.ucsf.edu/index.html

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By